Desale, Swapnil S <br/><br/>
Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.  [electronic resource] 

 -  Journal of controlled release : official journal of the Controlled Release Society  Jun 2015 
 - 59-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1873-4995 
<br/><br/><label>Standard No.: </label>10.1016/j.jconrel.2015.02.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Bacterial Agents--administration & dosage<br/>Benzoquinones--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Chemistry, Pharmaceutical<br/>Doxorubicin--administration & dosage<br/>Drug Compounding<br/>Drug Synergism<br/>Female<br/>Gels<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Lactams, Macrocyclic--administration & dosage<br/>Mice<br/>Mice, Nude<br/>Nanostructures--chemistry<br/>Receptor, ErbB-2--genetics<br/>Xenograft Model Antitumor Assays